Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Hospitals & Diagnostics
    • SRL Diagnostics to...

    SRL Diagnostics to invest Rs 300 cr in 5 yrs to expand network

    Written by savita thakur thakur Published On 2016-03-31T11:52:48+05:30  |  Updated On 31 March 2016 11:52 AM IST
    SRL Diagnostics to invest Rs 300 cr in 5 yrs to expand network

    New Delhi : SRL Diagnostics will invest over Rs 300 crore within 5 years to expand network as it looks to tie up with more states to open labs in government-run hospitals.


    The company has already entered into partnerships Himachal Pradesh, Jharkhand and Uttar Pradesh governments to establish labs in government run hospitals in these states.


    "The company is coming up with 150 labs in domestic market and 50 labs in international market in the next five years, which will be an addition to 306 labs that SRL has till now," SRL Ltd CEO Sanjeev Vashishta said in a statement.


    In order to fund the expansion plan, it has drawn up "an investment of more than Rs 300 crore in next five years".


    On the partnership with state governments, he said: "The infrastructure development in Indian diagnostic sector is limited and government has realised the need for PPP model to provide affordable and accessible diagnostics to the masses and to fill this existing vacuum."


    He further said, "We are also looking forward to extend our relationship with other state governments to ensure accurate and quality diagnosis is available to maximum number of people in the country."


    With plethora of unaccredited labs in these cities, such initiatives will also help raise the benchmark in diagnostic services in tier II and III cities, Vashishta added.


    In Himachal Pradesh, SRL now operates 24 labs, while in Jharkhand it has set up labs in government hospitals 12 districts in this fiscal. It had recently entered into a partnership with Uttar Pradesh government to establish collection centers in 22 districts to provide over 150 specialised tests.


    On the overall network expansion, the company said it plans to set up labs in places, including Cuttack, Hubli, Faizabad, Goa, Nashik, Allahabad, Karimganj.


    In the international market, it is eyeing Congo, Nigeria, Nepal, Sri Lanka, Bangladesh and Myanmar, the company said.

    PPPSanjeev VashishtaSRL Diagnostics
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    savita thakur thakur
    savita thakur thakur
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok